Completed
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
NCT05694819
- Conditions
- Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Nagoya University Hospital Nagoya, Aichi-ken, Japan
- Chiba University Hospital Chiba, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- National Hospital Organization Kyushu Medical Center Fukuoka, Japan